Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS)

Conclusion:
ASTRO-APS will be the largest prospective study to date comparing a direct oral anticoagulant with warfarin among patients with APS for the secondary prevention of thrombosis. Our inclusion criteria assure that outcomes obtained will be clinically applicable to the routine management of patients with APS receiving indefinite anticoagulation.

Source: Clinical and Applied Thrombosis/Hemostasis - February 22, 2016 Category: Hematology Authors: Woller, S. C., Stevens, S. M., Kaplan, D. A., Branch, D. W., Aston, V. T., Wilson, E. L., Gallo, H. M., Johnson, E. G., Rondina, M. T., Lloyd, J. F., Evans, R. S., Elliott, C. G. Tags: Original Articles Source Type: research